amfAR, The Foundation for AIDS Research
amfAR’s public policy office in Washington, D.C., educates policy makers, the media, and the public about evidence-based policies to address HIV/AIDS in the U.S. and around the world.
Over 3 million Americans have hepatitis C virus (HCV), and an estimated 75% are undiagnosed. But the CDC’s HCV surveillance system is seriously underfunded.
New database enables users to access and understand PEPFAR programs and priorities at a deeper level than was previously possible.
amfAR’s issue briefs and short films make a convincing case for ending the ban on federal funding for syringe services programs.
amfAR’s new Issue Brief warns of the free trade agreement’s potentially damaging effects on global public health.
Women and HIV/AIDS: Fast-Tracking the U.S. and Global Response.
Black Americans in states not expanding Medicaid are more than six times as likely to be diagnosed with HIV.
Report urges stronger, more consistent state leadership to help end the AIDS epidemic in the United States.
Stigmatized and criminalized, people who inject drugs are routinely denied access to vital HIV prevention and treatment services.
The number of Americans (3.2 million) living with chronic Hepatitis C Virus (HCV) is nearly five times the population of Washington, DC
Syringe services programs (SSPs) are proven to be a highly effective—and cost-effective—method of infectious disease prevention.
© 2015 amfAR All Rights Reserved